His primary areas of investigation include Immunology, Cell biology, Immune system, Cancer research and Receptor. His studies deal with areas such as Phenotype, Macrophage, Pancreatic cancer and Pancreas as well as Immunology. His work in Cell biology addresses subjects such as Cell growth, which are connected to disciplines such as Apoptosis, IRF1, T lymphocyte and Cell.
His research integrates issues of Cytokine, Alpha-enolase, Germinal center, Pancreatic ductal adenocarcinoma and Adenocarcinoma in his study of Immune system. His Cancer research course of study focuses on Phosphorylation and Proteomics and Extracellular Matrix Degradation. Francesco Novelli has researched Receptor in several fields, including Proinflammatory cytokine, Interferon, Signal transduction and Molecular biology.
Francesco Novelli focuses on Immunology, Cancer research, Pancreatic cancer, Immune system and Cell biology. The study incorporates disciplines such as Cytotoxic T cell and Interleukin 12 in addition to Immunology. Francesco Novelli has included themes like Tumor microenvironment, Cancer, Tumor progression, Cell and Autoantibody in his Cancer research study.
His Pancreatic cancer study also includes
His main research concerns Cancer research, Pancreatic cancer, Immune system, Immunotherapy and Immunology. His Cancer research research is multidisciplinary, relying on both Tumor microenvironment, Cancer, Tumor progression, Cell growth and Diabetes mellitus. His Pancreatic cancer research integrates issues from Chemotherapy, Glycolysis, Antigen, Metastasis and Alpha-enolase.
His work deals with themes such as Neuroscience, Symptom exacerbation and Disease course, which intersect with Immune system. As a member of one scientific family, Francesco Novelli mostly works in the field of Immunotherapy, focusing on DNA vaccination and, on occasion, Vaccination and Myeloid. His T cell study integrates concerns from other disciplines, such as Hypoxia and Cell biology.
Cancer research, Pancreatic cancer, Tumor microenvironment, T cell and Cell growth are his primary areas of study. Francesco Novelli interconnects Cancer, Tumor growth, Diabetes mellitus, Cardiotoxicity and Doxorubicin in the investigation of issues within Cancer research. His study looks at the relationship between T cell and fields such as Cell biology, as well as how they intersect with chemical problems.
His Immune system study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Epigenetics and Cytokine. Francesco Novelli focuses mostly in the field of Receptor, narrowing it down to matters related to Hypoxia and, in some cases, Immunology. His Immunology study combines topics in areas such as Proteomics and Warburg effect.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β†
Luca Durelli;Laura Conti;Marinella Clerico;Daniela Boselli.
Annals of Neurology (2009)
A hypermorphic IκBα mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency
Gilles Courtois;Asma Smahi;Janine Reichenbach;Rainer Döffinger.
Journal of Clinical Investigation (2003)
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential
L Valfrè di Bonzo;I Ferrero;C Cravanzola;K Mareschi.
Gut (2008)
STAT1 and STAT3 in tumorigenesis: A matter of balance.
Lidia Avalle;Sara Pensa;Gabriella Regis;Francesco Novelli.
JAK-STAT (2012)
α-Enolase: a promising therapeutic and diagnostic tumor target.
Michela Capello;Sammy Ferri-Borgogno;Paola Cappello;Francesco Novelli.
FEBS Journal (2011)
Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling.
Gabriella Regis;Sara Pensa;Daniela Boselli;Francesco Novelli.
Seminars in Cell & Developmental Biology (2008)
Distribution of interferon-γ receptor in human tissues
Guido Valente;Laurence Ozmen;Francesco Novelli;Massimo Geuna.
European Journal of Immunology (1992)
Macrophage PI3Kγ drives pancreatic ductal adenocarcinoma progression
Megan M. Kaneda;Paola Cappello;Abraham V. Nguyen;Natacha Ralainirina.
Cancer Discovery (2016)
Interferon‐γ receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death
Paola Bernabei;Eliana M. Coccia;Laura Rigamonti;Marita Bosticardo.
Journal of Leukocyte Biology (2001)
Regulation of Human Macrophage M1-M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1.
Federica Raggi;Simone Pelassa;Daniele Pierobon;Federica Penco.
Frontiers in Immunology (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Turin
University of Turin
George Mason University
George Mason University
Harvard University
Rockefeller University
University of Turin
University of Turin
University of Turin
Human Genome Sciences (United States)
Wuhan University
Institut de Ciència de Materials de Barcelona
University of Kansas
Lund University
University of Tübingen
Spanish National Research Council
University of Salerno
Brigham and Women's Hospital
International School for Advanced Studies
Trinity College Dublin
Brigham and Women's Hospital
University of Rochester
Northwestern University
King's College London
The University of Texas at Austin
Stanford University